Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
---|---|---|---|---|---|---|
2012-05-23 | Selexis (Switzerland) Fusion Antibodies Services (UK) | bioproduction services (antibody humanization, generation of CHO cell lines...) | Services contract | |||
2012-05-21 | Ventana Medical Systems, a member of the Roche Group (USA - Switzerland) Gen-Probe (USA) | ERG biomarker (measure of ERG protein expression through immunohistochemistry (IHC) in prostate tissue) | prostate cancer | licensing |
Cancer - Oncology | Licensing agreement |
2012-05-21 | Provence Technologies (France) Neuroptis Biotech (France) | ML7 | dry eye syndrome | development |
Ophtalmological diseases | Development agreement |
2012-05-17 | Dako (Denmark) Van Andel Research Institute (USA) | MET4 antibody | licensing |
Cancer - Oncology | Licensing agreement | |
2012-05-16 | Lonza (Switzerland) Avalanche Biotechnologies (USA) | adeno-associated viral (AAV) vectors for gene therapy | manufacturing |
Production agreement | ||
2012-05-16 | ReNeuron (UK) Angel Biotechnology (UK) | ReN001 | stroke | manufacturing |
Cerebrovascular diseases | Production agreement |
2012-05-16 | Siemens Healthcare Diagnostics France (France) SmartGene (Switzerland) | SmartGene HIV-1 Starter Module | HIV-Aids | distribution |
Infectious diseases | Distribution agreement |
2012-05-15 | Debiopharm (Switzerland) Vifor Pharma (Switzerland) | Pamorelin® LA (triptorelin in the form of pamoate salt), Salvacyl® | prostate cancer, endometriosis | distribution |
Cancer - Oncology - Gynecology - Women's health | Commercialisation agreement |
2012-05-15 | Scil Proteins (Germany) Ono Pharmaceutical (Japan) | new Affilin® therapeutics to treat various diseases | undisclosed diseases | R&D |
undisclosed | R&D agreement |
2012-05-15 | Angel Biotechnology (UK) Cardium Therapeutics (USA) | Excellagen® (high molecular weight fibrillar bovine Type I topical gel (2.6%) specifically engineered as an adjunct to debridement for the management of diabetic foot ulcers and other dermal wounds) | diabetic foot ulcers and other dermal wounds | manufacturing |
Metabolic diseases - Cardiovascular diseases | Production agreement |
2012-05-15 | Selexis (Switzerland) Adienne Pharma (Italy) | orphan drugs | services |
Rare diseases | Services contract | |
2012-05-14 | Neurotune (Switzerland) The ALS Therapy Development Institute - ALS TDI (UK) | novel class of compounds to maintain neuromuscular junction strength and stability | amyotrophic lateral sclerosis | Neurodegenerative diseases - Rare diseases | Collaboration agreement | |
2012-05-09 | Nuevolution (Denmark) Boehringer Ingelheim (Germany) | drug candidates against drug targets of interest to Boehringer Ingelheim | R&D |
Milestone | ||
2012-05-09 | Evotec (Germany) 4-Antibody (Germany) | antibody discovery and development service | R&D |
Services contract | ||
2012-05-09 | Vivalis (France) Biodiem (Australia) | use of LAIV (Live Attenuated Influenza Virus) as a vector in Vivalis' proprietary cell line | nasopharyngeal carcinoma and respiratory syncytial virus infection | Infectious diseases | R&D agreement | |
2012-05-09 | Roche 454 Life Sciences (Switzerland - USA) SoftGenetics (USA) | NextGENe® software | co-promotion |
Technology - Services | Co-promotion agreement | |
2012-05-08 | Bayer (Germany) Regeneron Pharmaceuticals (USA) Santen (Japan) | EYLEA® (aflibercept) | neovascular age-related macular degeneration (wet AMD) | co-promotion |
Ophtalmological diseases | Co-promotion agreement |
2012-05-08 | Multiplicom (Belgium) ICAN (France) ICM (France) | genetic tests in cardiovascular, metabolic and neurological diseases | cardiovascular, metabolic (diabetes...) and neurological diseases | R&D |
Cardiovascular diseases - Metabolic diseases - Neurological diseases | R&D agreement |
2012-05-04 | OPKO Health (USA) International Health Technology (UK) | kallikrein biomarkers and associated algorithm for the detection of prostate cancer | prostate cancer | licensing |
Cancer - Oncology | Licensing agreement |
2012-05-03 | Sartorius Stedim (Germany) c-LEcta (Germany) | Denarase (Serratia marcescens nuclease for biopharmaceutical applications) | distribution |
Distribution agreement |